Intramuscular lorazepam to restrain violent patients

Quality of life with talazoparib after platinum or multiple cytotoxic non-platinum regimens in patients with advanced breast cancer and germline BRCA1/2 mutations: patient-reported outcomes from the ABRAZO phase 2 trial.

European journal of cancer (Oxford, England : 1990)·2018

Quality of life with talazoparib versus physician's choice of chemotherapy in patients with advanced breast cancer and germline BRCA1/2 mutation: patient-reported outcomes from the EMBRACA phase III trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2018

A multicenter, open-label, expanded phase 2 study to evaluate the safety and efficacy of etirinotecan pegol, a polymer conjugate of irinotecan, in women with recurrent platinum-resistant or refractory ovarian cancer.

Gynecologic oncology·2017

Phase I study of the heat shock protein 90 inhibitor alvespimycin (KOS-1022, 17-DMAG) administered intravenously twice weekly to patients with acute myeloid leukemia.

Leukemia·2010

Kinases as drug discovery targets in hematologic malignancies.

Current molecular medicine·2005

Pediatric phase I trial and pharmacokinetic study of the platelet-derived growth factor (PDGF) receptor pathway inhibitor SU101.

Cancer chemotherapy and pharmacology·2004

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

Lancet (London, England)·2026

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Workplace Violence Before and During the COVID-19 Pandemic: Occupational Disparities in Nonfatal Violent Victimization.

Journal of interpersonal violence·2026

Surprise, He's Innocent: The Character Trope of the Wrongfully Accused White Man in the #MeToo Era.

Violence against women·2026

Virologist accused of starting COVID-19 fights funding ban.

Science (New York, N.Y.)·2026

Off-Road Vehicle Trauma in Southern California: Association With the Social Vulnerability Index.

The American surgeon·2026

Welfare Compliance and Domestic Violence: How Australia's Welfare Fraud Tip-Off Line is Used as a Tool of State Violence Against Women.

Violence against women·2026

Artificial Neural Networks for Discrimination of Automotive Clear Coats by Vehicle Manufacturer.

Sensors (Basel, Switzerland)·2026

Related Experiment Videos

Intramuscular lorazepam to restrain violent patients

Related Concept Videos

Quality of life with talazoparib after platinum or multiple cytotoxic non-platinum regimens in patients with advanced breast cancer and germline BRCA1/2 mutations: patient-reported outcomes from the ABRAZO phase 2 trial.

Quality of life with talazoparib versus physician's choice of chemotherapy in patients with advanced breast cancer and germline BRCA1/2 mutation: patient-reported outcomes from the EMBRACA phase III trial.

A multicenter, open-label, expanded phase 2 study to evaluate the safety and efficacy of etirinotecan pegol, a polymer conjugate of irinotecan, in women with recurrent platinum-resistant or refractory ovarian cancer.

Phase I study of the heat shock protein 90 inhibitor alvespimycin (KOS-1022, 17-DMAG) administered intravenously twice weekly to patients with acute myeloid leukemia.

Kinases as drug discovery targets in hematologic malignancies.

Pediatric phase I trial and pharmacokinetic study of the platelet-derived growth factor (PDGF) receptor pathway inhibitor SU101.

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Workplace Violence Before and During the COVID-19 Pandemic: Occupational Disparities in Nonfatal Violent Victimization.

Surprise, He's Innocent: The Character Trope of the Wrongfully Accused White Man in the #MeToo Era.

Virologist accused of starting COVID-19 fights funding ban.

Off-Road Vehicle Trauma in Southern California: Association With the Social Vulnerability Index.

Welfare Compliance and Domestic Violence: How Australia's Welfare Fraud Tip-Off Line is Used as a Tool of State Violence Against Women.

Artificial Neural Networks for Discrimination of Automotive Clear Coats by Vehicle Manufacturer.

Related Experiment Videos

Intramuscular lorazepam to restrain violent patients

Related Concept Videos

Related Articles